Clinical Trials Sponsored by Abbott Molecular

Total 2344 results

Abbott

Completed

Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent

HIV Infections

United States
Abbott

Terminated

Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy

HIV Infection

United States
Abbott

Completed

Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer

Prostatic Neoplasms

United States
Abbott

Completed

Safety of Treatment of Uterine Fibroids With Asoprisnil

Metrorrhagia | Leiomyoma | Uterine Fibroids | Menorrhagia | Fibroid Uterus
Abbott

Completed

A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in the Treatment of Women With Endometriosis

Endometriosis
Abbott

Completed

Study of Asoprisnil in the Treatment of Uterine Fibroids.

Metrorrhagia | Leiomyoma | Uterine Fibroids | Menorrhagia | Fibroid Uterus
Abbott

Approved for marketing

Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis (ReAct)

Rheumatoid Arthritis
Abbott

Completed

Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART

HIV Infections

France, Spain, United States, Canada, Poland, Argentina, Brazil, Germany, Italy, Puerto Rico, United Kingdom
Abbott

Completed

Paricalcitol Injection Phase II Trial

Chronic Kidney Disease

Japan
Abbott

Completed

A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis

End Stage Renal Disease

Poland, United States
Abbott

Completed

Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy

Arthritis | Psoriatic
Abbott

Completed

A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension Medications

Healthy

United States
Abbott

Completed

A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amoxicillin Antibiotic Suspension Medications

Healthy

United States
Abbott

Completed

Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets to 7 Days of Clarithromycin Immediate-Release Tablets for the Treatment of Exacerbation of Chronic Bronchitis

Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB).

United States, Canada, Puerto Rico
Abbott

Completed

A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amoxicillin/Clavulanate in Pediatric Subjects With Acute Otitis Media

Acute Otitis Media

United States
Abbott

Completed

Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma

Sarcoma, Soft Tissue

United States
Abbott

Completed

A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.

Breast Cancer

United States
Abbott

Completed

Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatment of Adolescents With Migraine

Migraine

United States
Abbott

Completed

A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder

Obesity | Binge Eating Disorder
Abbott

Completed

A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488.

Migraines

United States
Abbott

Completed

A Study for Treatment of Partial Seizures in Children

Partial Seizures

United States
Abbott

Terminated

A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease

Alzheimer's Disease

United States
Abbott

Completed

Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure

Prostatic Neoplasms

United States, Canada
Abbott

Completed

Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)

Renal Insufficiency, Chronic

United States, Poland
Abbott

Completed

A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

Crohn's Disease

United States
Abbott

Completed

Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium

Chronic Kidney Disease | Secondary Hyperparathyroidism

United States
Abbott

Completed

Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)

Renal Insufficiency, Chronic

United States, Poland
Abbott

Completed

A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects

Hypocalcemia

United States
Abbott

Completed

Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor

HIV Infections

Spain, United Kingdom, United States, Canada, France, Poland, Argentina, Brazil, Italy, Puerto Rico
NeuMoDx Molecular, Inc.
NAMSA

Completed

NeuMoDx PrEDiCTiNG Study Evaluation Plan

Neisseria Gonorrheae Infection | Chlamydia Trachomatis Infection

United States
Molecular Insight Pharmaceuticals, Inc.

Approved for marketing

Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma

Pheochromocytoma | Paraganglioma

United States
Life Molecular Imaging SA

Terminated

PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer

Prostate Cancer

Austria, Finland
Life Molecular Imaging SA

Completed

Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology

Alzheimer Disease

United States, France, Japan, Australia, Germany
Molecular Insight Pharmaceuticals, Inc.

Completed

Safety and Efficacy Iodofiltic Acid I 123 in the Treatment of Acute Coronary Syndrome (Zeus-ACS)

Acute Coronary Syndrome

United States, Canada
Molecular Insight Pharmaceuticals, Inc.

Withdrawn

Study to Evaluate the Efficacy and Safety of 90Y-SMT487 in Subjects With Symptomatic Malignant Carcinoid Tumors

Malignant Carcinoid Tumor
Molecular Insight Pharmaceuticals, Inc.

Completed

Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection

Prostate Cancer

United States
Molecular Insight Pharmaceuticals, Inc.

Completed

99mTc-MIP-1404 for Imaging Prostate Cancer: Phase I Clinical Study to Assess the Image Quality of a Simplified Kit Formulation Compared to a Multi-step Preparation of 99mTc-MIP-1404

Prostate Cancer

United States
Life Molecular Imaging SA

Completed

Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients

Alzheimer Disease | Amyloid Beta-Protein

Australia
Life Molecular Imaging SA

Completed

Phase II Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid.

Down Syndrome | Amyloid Beta-protein

United States
Life Molecular Imaging SA

Completed

PET/CT (Positron Emission Tomography/Computed Tomography) Imaging for Safety and Tolerability and Diagnostic Performance of BAY1075553 in Patients With Prostate Cancer and Healthy Volunteers

Diagnostic Imaging

Austria, United States
Life Molecular Imaging SA

Completed

Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy Volunteers

Diagnostic Imaging

Sweden, Finland
Molecular Insight Pharmaceuticals, Inc.

Completed

Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents

Prostate Cancer

United States
Molecular Insight Pharmaceuticals, Inc.

Terminated

Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic Melanoma

Metastatic Melanoma

United States
Abbott Medical Devices
Abbott

Completed

LV Only MPP With SyncAV

Heart Failure | Left Bundle-Branch Block

United Kingdom, France, Italy, Canada
Abbott Medical Devices
Abbott

Completed

MitraClip NT System Post-marketing Surveillance Study - Japan (MitraClip NT)

Mitral Regurgitation | Mitral Valve Regurgitation

Japan
Abbott Medical Devices
Abbott

Terminated

MitraClip System in Australia and New Zealand (MitraClipANZ)

Mitral Regurgitation

Australia
Abbott Products
Datamap

Completed

Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis

Pancreatic Insufficiency

India
Molecular Insight Pharmaceuticals, Inc.

Completed

Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer (proSPECT-AS)

Prostate Cancer

United States, Canada
Molecular Insight Pharmaceuticals, Inc.

Completed

N2007-01: Ultratrace™ Iobenguane I 131 in Patients With Relapsed/Refractory High-Risk Neuroblastoma

Neuroblastoma

United States
Molecular Insight Pharmaceuticals, Inc.

Completed

A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology

Prostate Cancer

United States, Belgium, Italy, Czech Republic, Hungary, Netherlands, Poland, Russian Federation

3

Subscribe